FDA Takes Enforcement Action Against CardioMEMS For Alleged Clinical Trial Violations
This article was originally published in The Gray Sheet
Executive Summary
A warning letter cites violations related to the pivotal trial of the firm's Champion HF implantable heart failure monitor.